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Abstract
Introduction: Hemodialysis (HD) patients are 
predisposed to infective endocarditis (IE) mainly due to 
repeated manipulation of the vascular access. However, 
catheter seeding and IE may also result from a distant 
infection site.
Case series: A diabetic patient who was maintained 
on regular HD through a permanent catheter in the 
right internal jugular vein presented with septicemia of 
urinary origin due to Pseudomonas aeruginosa. He was 
treated with injectable antibiotics for 15 days. Few days 
after the end of the treatment period he presented with 
inflammation of the catheter exit site. Blood cultures 
revealed Pseudomonas aeruginosa and echocardiography 
showed a large vegetation on the tricuspid valve, 
confirming the diagnosis of IE. The patient improved 
after catheter removal and treatment with ceftazidime, 
vancomycin and amikacin. Another patient who was 
maintained on chronic HD through a tunneled catheter 
in the right internal jugular vein presented with a limited 
infection in the sub-cutaneous tunnel of the catheter that 
improved after treatment with injectable antibiotics. Two 
months later, he presented with severe sepsis without 
signs of local infection of the catheter. Chest radiography 
showed right sided infiltrates. Injectable antibiotic therapy 
was given without improvement. Blood cultures were 
negative but echocardiography showed a large tricuspid 
valve vegetation. Antibiotic regimen was modified to 
include vancomycin, amikacin and ceftazidime and the 
catheter was removed. Unfortunately, the patient died 
two days after diagnosing IE. 
Conclusion: catheter seeding and IE may be a 
consequence of sepsis originating away from the HD 
catheter site. Tunneled catheters may need to be pre-
emptively removed in such situations to prevent serious 
IE. 
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Editorial Comment
The manuscript describes two cases of infective 
endocarditis thought to be due to distant infection with or 
without secondary seeding of the fixed jugular catheters. 
Authors aimed to stress the message that central catheters 
should be removed in bacteremic patients in order to 
prevent or reduce the incidence of infective endocarditis 
and they have referred to paucity of literature information 
in this regard.  
Indeed, catheter-related bactermia has been regularly 
investigated over the past 2 decades but the question of 
catheter removal in patients with bactermia due to distant 
infection is not easy to answer. In this later situation, it is 
usually difficult to verify catheter bacterial seeding and 
hence, to predict the likelihood of catheter contribution 
to persistence of infection or response to treatment. The 
implicitly stated answer in the literature is that catheter 
should be removed if the patient is hemodynamically 
unstable, or if he does not show a satisfactory initial 




Infections are the second most common cause of 
mortality among chronic hemodialysis (HD) patients after 
cardiovascular causes. The predisposition to infections is 
mainly linked to the repeated manipulation of the vascular 
access. Bacteremia incidence is dependent on the type 
of vascular access used; being higher with permanent 
catheters and synthetic grafts than native arteriovenous 
fistulas [1, 2]. Alteration of the immune system in the 
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chronic HD patient also contributes to the predisposition 
to infections [3]. Moreover, the bone mineral disorder 
and chronic inflammation observed in chronic HD lead to 
valvular and perivalvular calcifications and changes [4]. 
These alterations occur at an early stage of renal failure and 
primarily involve the mitral and aortic valves [5]. In this 
context, infectious endocarditis should be very frequent, 
but only few series are published in the literature. This 
apparent under-reporting of the incidence of infectious 
endocarditis among chronic HD patients with bacteremia 
is probably related to the difficulty of diagnosing IE and/
or to the treating doctors’ unfamiliarity with IE. 
Case 1
This is a 56-year-old Caucasian male patient, type 2 
diabetic since 2002, on chronic HD since February 2011. 
Periodic HD was initiated with a permanent catheter in 
the right internal jugular vein after immediate failure of 
three upper limb native arteriovenous fistulas that were 
never punctured. In November 2011, the patient presented 
with vomiting, asthenia, temperature of 40°C, chills with 
burning sensations during micturition. The blood workup 
showed leukocytosis with 17,000 cells/mm3, anemia with 
hemoglobin of 7 g/dL, and a serum C reactive protein level 
of 80 mg/L. Cyto-bacteriological examination of the urine 
identified Pseudomonas aeruginosa. The diagnosis of 
septicemia of urinary origin was adopted; treatment based 
on injectable ceftriaxone and ciprofloxacin was initiated 
and continued for 15 days. However, a few days after the 
end of treatment, signs of infections reappeared, this time 
in the form  of bronchitis, while the urinary symptoms 
had disappeared. Examination of the patient revealed 
inflammation of the catheter exit site with exudation of 
pus. Blood cultures performed on peripheral blood and 
blood contained in the catheter revealed Pseudomonas 
aeruginosa. Laboratory workup showed elevated serum 
concentrations of pro-calcitonin (5 ng/mL), C reactive 
protein (160 mg/dL) and erythrocyte sedimentation rate 
(136 mm/h). Abdominal ultrasound showed significant 
splenomegaly and transthoracic echocardiography 
showed a large vegetation on the tricuspid valve 1.2 x 1.0 
cm with grade III tricuspid regurgitation. The diagnosis 
of IE on a native tricuspid valve was made. Thoracic CT 
angiography was performed and did not show signs of 
pulmonary infarction. The tunneled catheter was removed, 
antibiotic treatment based on ceftazidime, vancomycin 
(trough level kept between 20 and 25 mg/L) and amikacin 
was initiated to cover both pseudomonal and a possible 
staphylococcal infections. Treatment duration was six 
weeks. Dialysis sessions were maintained and carried 
out using a temporary femoral catheter placed five days 
after removal of the first tunneled catheter. Recovery 
under treatment was favorable, with apyrexia achieved 
72 hours after the start of antibiotic treatment and 
progressive normalization of all biological parameters. 
Weekly echocardiograms were performed and showed no 
worsening of the cardiac function. Decrease in the size of 
vegetation (1.1 x 0.9 cm) was documented three months 
after the start of the treatment. No septic embolism was 
noted, and one year after the endocarditis episode, the 
patient remained stable from a cardiac standpoint.     
Case 2
This is a 37-year-old Caucasian male patient on chronic 
HD since January 2005 with ESRD due to undetermined 
etiology. The patient was addict to cannabis and his 
serology was positive for both hepatitis C and B viruses 
and he had never received treatment for the viral hepatitis. 
He underwent placement of seven native arteriovenous 
fistulas, which were complicated by immediate or early 
thrombosis and needed four short-term catheters for 
dialysis. An initial tunneled central venous catheter was 
inserted in the right internal jugular vein in September 
2010 and was removed 6 months later due to a catheter-
related bacteremia. A second tunneled catheter using the 
left internal jugular vein was inserted in March 2011. In 
August 2012, the patient presented with a limited infection 
in the sub-cutaneous tunnel of the catheter. Given the 
absence of fever, clinical features of infectious process, 
and because of the difficulty of obtaining another vascular 
access; injectable antibiotic therapy was given with 
favorable clinical response. In October 2012, the patient 
presented with severe sepsis of pulmonary origin without 
signs of local infection of the catheter. The blood workup 
showed leukocytosis with 15,000 cells/mm3, anemia with 
hemoglobin of 5 g/dL, and a serum C reactive protein 
level of 190 mg/L. Chest radiography showed right sided 
infiltrates. Injectable antibiotic therapy was begun with 
a third generation cephalosporin and ciprofloxacin. In 
view of the lack of clinical and biological improvement, 
an echocardiography was performed and showed a 
large tricuspid valve vegetation 2.7 x 1.2 cm. Antibiotic 
regimen was modified to include vancomycin, amikacin 
and ceftazidime. The catheter was removed. The blood 
cultures carried out returned negative. Forty eight 
hours after the IE diagnosis, the patient died following 
respiratory failure most likely secondary to a massive 
septic pulmonary embolism. 
Discussion
Infective endocarditis (IE) in hemodialysis (HD) is 
significantly more common and causes greater morbidity 
and mortality than in the general population. Its incidence 
is estimated to be 308/100,000 patient-years, which is 50 
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to 180- fold higher than the 1.7 to 6.2 cases per 100,000 
patient-years reported for the general population [6, 7].
The use of a permanent or temporary catheter is strongly 
associated with IE in dialysis patients and exceeds 60% 
in some series [8, 9]. Diabetes mellitus is also often 
associated with the occurrence of IE in dialysis patients 
[8-10]. IE in patients on chronic HD affects mainly native 
valves accounting for more than 80% of cases. The mitral 
valve is involved in more than 50% of cases, the aortic 
valve in more than 30% and concomitant involvement 
of both valves is relatively frequent. The tricuspid valve 
is rarely affected. In large series involvement of the 
tricuspid valve varies from 6.2% to 19% [8, 9, 14].
Staphylococcus aureus is the main cause of vascular 
access-related bacteremia among patients receiving long 
term HD (up to 70% of cases) [8, 11, 13, 14]. Enterococcus 
and streptococcus are in second place (10-30%) [9, 12]. 
The gram-negative species are rarely found (0-13%) 
[8-12]. Pseudomonas has been identified in only two series 
[8, 10]. The clinical, microbiological, echocardiographic 
and prognostic features of IE in chronic HD reported by 
recent studies are shown in Table-1. 
Treatment is primarily medical, consisting of antibiotic 
treatment adapted to the organism identified in blood 
cultures. When a permanent catheter is used, its removal 
and the later insertion of a second catheter are highly 
recommended. 
Herein, we report two cases of severe IE of the tricuspid 
valve in two chronic HD patients with multiple 






















Number of cases 5 6 16 69 54 40 30
History of diabetes mellitus - - 6.2% 37.7% 42% 50% 28.5%
Access type
    Arteriovenous fistula or graft
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Blood culture negative 20% 33% 6.5% 0% 2% 10% -
Organism
    Staphylococcus
    Enterococcus
    Streptococcus
    Gram negative species   
    Pseudomonas aeruginosa 
    Klebsiella pneumoniae
    Candida species






























Valvular Surgery 40% 50% 31% 21.7% 24% 37.5% 40%
Mortality 60% 25% 44% 49.3% 61% 52.5% 31%
Table-1: The clinical, microbiological, echocardiographic and prognostic features of infective endocarditis in chronic 
hemodialysis reported by recent studies
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vascular access points. The patients were dialyzed by 
internal jugular tunneled catheters. In both cases, the IE 
episodes were preceded by severe sepsis of urinary and 
pulmonary origins without clinical signs of catheter or 
tunnel infection. 
These cases raise a question not adequately addressed 
in guidelines regarding such infections in chronic HD 
patients who are in a state of immune system alteration. 
Should the tunneled catheter be removed when bacteremia 
secondary to a distant infection not related to the catheter 
is detected? Furthermore, how should one proceed when 
the situation involves a precious vascular access with 
difficulty in obtaining another vascular access in a timely 
fashion?  
Conclusion
Infection of permanent or temporary central venous 
catheters constitutes the main portal of entry for IE. 
However, catheter seeding and IE may also be a 
consequence of sepsis originating away from the catheter 
site. Tunneled catheters may need to be pre-emptively 
removed in such situations to prevent serious IE. More 
studies are needed to guide practice in this clinical 
scenario.
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